Latest Dual Listing News

Trigg Minerals has secured a dual listing on the U.S. OTCQB market, enhancing accessibility for American investors and positioning itself for critical funding opportunities.

Resouro Strategic Metals Inc. posted a $5.28 million net loss for the nine months ended December 31, 2024, reflecting increased exploration and administrative expenses as it advances its Tiros Titanium and Rare Earth Elements Project. The company bolstered its balance sheet with a successful ASX dual listing and private placements but faces ongoing challenges to sustain operations.

Wellnex Life Limited has initiated a $22.1 million entitlement offer priced at $0.65 per share, coinciding with its proposed dual listing on the London Stock Exchange's AIM market, driven by strong UK institutional interest.

Radiopharm Theranostics' RAD 101 radiotracer demonstrates high sensitivity in detecting brain metastases using a novel PET-mpMRI approach, with a Phase 2b trial now recruiting in the US.

Benz Mining has launched its inaugural drilling campaign at the Glenburgh Gold Project in Western Australia, aiming to expand high-grade gold resources with results expected to shape an updated mineral resource estimate later this year.

Wellnex Life Limited reported a 36% rise in Q2 FY25 cash receipts and record monthly sales, while advancing its dual listing on the London Stock Exchange and expanding into the UK market.

Cygnus Metals has completed its merger with Doré Copper, securing a strong cash position and delivering promising early drilling results at its Chibougamau Project in Quebec. The company is poised for an aggressive exploration and resource growth campaign in 2025.

FireFly Metals reports a substantial 42% increase in its Green Bay Copper-Gold Project resource, underpinned by strong drilling results and a successful A$73 million capital raise. The company is well-positioned to accelerate development and regional exploration in 2025.

MTM Critical Metals reported major progress in its Flash Joule Heating technology and secured $15.5 million in capital raises, positioning itself for commercialisation and strategic growth in critical metals recovery.

Radiopharm Theranostics has secured key ethics approvals to expand its clinical trial portfolio, completed significant preclinical milestones, and raised A$8 million through a strategic placement, while maintaining its cash runway to mid-2026.

Tesoro Gold reports its highest-ever gold assay at the Ternera Deposit alongside a strategic dual listing on the Frankfurt Stock Exchange and a strong cash position.

Redivium's Q2 FY25 report reveals strategic progress in lithium-ion battery recycling across Europe, including new partnerships and feasibility studies, while navigating tight cash reserves and a critical entitlement offer.